Skip to main content
Top
Published in: Osteoporosis International 3/2017

01-03-2017 | Case Report

Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates

Authors: A. Sánchez, R. Blanco

Published in: Osteoporosis International | Issue 3/2017

Login to get access

Abstract

The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999–2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006–2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of −2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman.
Literature
1.
go back to reference Fleisch H (1987) Bisphosphonates—history and experimental basis. Bone 8(Suppl 1):S23–S28PubMed Fleisch H (1987) Bisphosphonates—history and experimental basis. Bone 8(Suppl 1):S23–S28PubMed
2.
go back to reference Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16–35CrossRefPubMedPubMedCentral Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16–35CrossRefPubMedPubMedCentral
3.
go back to reference Sánchez A (2008) [What are atypical femoral fractures?] (editorial; Spanish). Actual Osteol 8:145–149 Sánchez A (2008) [What are atypical femoral fractures?] (editorial; Spanish). Actual Osteol 8:145–149
4.
go back to reference Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRefPubMed Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRefPubMed
5.
go back to reference Bogdan Y, Tornetta P 3rd, Einhorn TA et al (2016) Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: a multicenter retrospective cohort. J Orthop Trauma 30:177–181CrossRefPubMed Bogdan Y, Tornetta P 3rd, Einhorn TA et al (2016) Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: a multicenter retrospective cohort. J Orthop Trauma 30:177–181CrossRefPubMed
6.
go back to reference Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23CrossRefPubMed Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23CrossRefPubMed
7.
go back to reference Kharazmi M, Hallberg P, Michaëlsson K (2014) Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw (letter). Ann Rheum Dis 73:1594CrossRefPubMed Kharazmi M, Hallberg P, Michaëlsson K (2014) Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw (letter). Ann Rheum Dis 73:1594CrossRefPubMed
8.
go back to reference Compston J (2011) Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw (review). Osteoporos Int 22:2951–2961CrossRefPubMed Compston J (2011) Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw (review). Osteoporos Int 22:2951–2961CrossRefPubMed
9.
go back to reference Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23CrossRefPubMed Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23CrossRefPubMed
10.
go back to reference Chiu WH, Lee JJ, Tsai KS (2013) Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis. J Clin Endocrinol Metab 98:E723–E726CrossRefPubMed Chiu WH, Lee JJ, Tsai KS (2013) Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis. J Clin Endocrinol Metab 98:E723–E726CrossRefPubMed
11.
go back to reference Won Y, Lim JR, Kim YH, Song HK, Yang KH (2014) Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab 21:155–160CrossRefPubMedPubMedCentral Won Y, Lim JR, Kim YH, Song HK, Yang KH (2014) Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab 21:155–160CrossRefPubMedPubMedCentral
12.
go back to reference Kim JE, Yun M, Lim SK, Rhee Y (2015) Concurrent bisphosphonate-related bilateral atypical subtrochanteric fractures and osteonecrosis of the jaw on bone scintigraphy. Clin Nucl Med 40:450–452CrossRefPubMed Kim JE, Yun M, Lim SK, Rhee Y (2015) Concurrent bisphosphonate-related bilateral atypical subtrochanteric fractures and osteonecrosis of the jaw on bone scintigraphy. Clin Nucl Med 40:450–452CrossRefPubMed
13.
go back to reference Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251–2255CrossRefPubMed Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251–2255CrossRefPubMed
Metadata
Title
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates
Authors
A. Sánchez
R. Blanco
Publication date
01-03-2017
Publisher
Springer London
Published in
Osteoporosis International / Issue 3/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3840-z

Other articles of this Issue 3/2017

Osteoporosis International 3/2017 Go to the issue